I found these 10 short video series from OncLive very useful. Each video ranges from 2 – 5 minutes long and is very easy to watch and digested. Not only a succinct primer on (so-called) carcinoid syndrome but also an update on the evolving approaches. And the series also includes information on Hedinger Syndrome (carcinoid heart disease) which can be caused by the effects of this syndrome.
The panel includes some ‘big hitter’ names in our scientific community including:
Satya (Nanu) Das, MD, MSCI (Oncologist)
Jerome Zacks, MD (Cardiologist)
Rodney Pommier, MD (Surgeon)
Video list (click on the blue link to watch each one)
Episode 1 – Overview of Neuroendocrine Tumors (NETs) (onclive.com)
Episode 2 – Overview of Carcinoid Syndrome (CS) (onclive.com)
Episode 3 – Overview of Carcinoid Heart Disease (CHD) (onclive.com)
Episode 4 – Management of Carcinoid Syndrome-Related Symptoms (onclive.com)
Episode 5 – Diagnosis and Management of Somatostatin Analog-Refractory Carcinoid Syndrome (onclive.com)
Episode 6 – Available Treatment Options for Somatostatin Analog-Refractory Carcinoid Syndrome (onclive.com)
Episode 7 – Data from the TELEPATH Trial and Real-World Analyses (onclive.com)
Episode 8 – Prevention, Treatment, and Management of Carcinoid Heart Disease (onclive.com)
Episode 9 – Unmet Needs for Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome (onclive.com)
Episode 10 – Advice for Community Physicians Treating Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome (onclive.com)
The Syndromes of Neuroendocrine Cancer – Early signs of a Late Diagnosis?
Carcinoid syndrome is only one of several hormonal syndromes involved, read about the others here.
Neuroendocrine Cancer – don’t break my heart
My compendium of information contains more detail on Hedinger Syndrome (carcinoid heart disease).
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me. Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional as they are not members of the private group or followers of my sites in any official capacity. Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Top 10 Posts & Pages in the last 48 hours (auto updates)
Thanks for reading.
I’m also active on Facebook. Like my page for even more news. Help me build up my new site here – click here and ‘Like’
Sign up for my newsletters – Click Here
My Diagnosis and Treatment History
Check out my online presentations
Check out my WEGO Health Awards
Like my new awareness page – click here or on the photo. (Like rather than follow please!)
Check out my Glossary of Terms – click on the picture:
Remember ….. in the war on Neuroendocrine Cancer, let’s not forget to win the battle for better quality of life!
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Pancreatic NET with carcinoid syndrome – not as common as you think
Why do I need to write about this? I’ve been watching confusion surrounding symptomatic pancreatic NETs for years and it never ceases to amaze me
A spotlight on Appendiceal Neuroendocrine Neoplasms
What are Appendiceal NENs Appendiceal Neuroendocrine Neoplams (NENs) account for approximately 60% of all primary cancers in the appendix. The other main cancer types found
Nuclidium wins award to study NET radiopharmaceutical – Phase 1 Clinical Trial of TraceNET (TM)
What is TraceNETTM TraceNETTM is a a novel copper-based ‘radiodiagnostic’ for detecting neuroendocrine tumours (NET). The PET imaging agent candidate is the diagnostic component of
Experimental drug for Gastric NET – Netazepide
Gastric NETs When I wrote my post entitled “Spotlight on Gastric Neuroendocrine Neoplasms“, I explained what these were with some emphasis on the association with
A Newsletter from RonnyAllan.NET – 13th March 2023
Newsletter from Ronny Allan – 13th March 2023 Welcome to my new template newsletter compiled using WordPress (my blog app). This is the 2nd in
Fructose intolerance – the NET Effect
Background When I cast my mind back to my very first surgery, I remember all sorts of ‘plumbing’ issues but was told it would take
A tribute to the life and legacy of Miranda Filmer
It’s true to say that Neuroendocrine Cancer is an older person’s disease, the epidemiology is clear on that. But I do see many young people
Treatment for Neuroendocrine Cancer: Beware of the alternatives
The Alternative Hype Cancer Research UK warns of the risks in Alternative Therapies, and I pay great attention to what these guys say. I know
RonnyAllan.NET – Summary of February 2023 – Ronny Allan – Living with Neuroendocrine Cancer
Summary Another great start to 2023 and I thank those who continue to support my social media and this blog. I’m keen to hear any